跳至主要内容
临床试验/EUCTR2020-003410-12-GB
EUCTR2020-003410-12-GB进行中(未招募)1 期

Pregnancy ANtihypertensive Drugs: which Agent is best? - Giant PANDA

niversity of Birmingham0 个研究点目标入组 2,300 人开始时间: 2020年12月4日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
2,300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • TRIAL INCLUSION CRITERIA:
  • -Pregnancy 11+0 and 34+0 weeks’ gestation inclusive
  • -Diagnosis of pregnancy hypertension (chronic/gestational hypertension or pre-eclampsia)
  • -Clinician decision to initiate or continue use of antihypertensive drugs
  • -Aged 18 years or over
  • -Able to give informed consent
  • OBSERVATIONAL STUDY INCLUSION CRITERIA:
  • Women will be eligible to participant in the observational study at any gestational age up to and including 34+0 weeks. Women are able to take part in the observational study prior to 11+0 weeks gestation where use of any antihypertensive drugs prescribed in clinical care will be recorded but will not form part of the interventional trial.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 2300
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range 0

排除标准

  • TRIAL EXCLUSION CRITERIA:
  • -Contraindication to either labetalol or nifedipine
  • -Already taking both labetalol and nifedipine, and not able to be randomised to a single drug
  • OBSERVATIONAL STUDY EXCLUSION CRITERIA:
  • Neither exclusion criterion for the trial are relevant for the observational study. Women contraindicated to either labetalol or nifedipine and/or women already taking both labetalol and nifedipine and not able to be randomised to a single drug, are eligible for the observational study.

研究者

相似试验

Pregnancy ANtihypertensive Drugs: which Agent is... | 临床试验